Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vestibular vs Sublingual AIT for Allergic Rhinitis
NCT05119751Phase 4Completed
- Sponsor
- Clinique Spécialisée en Allergie de la Capitale
- Start
- Oct 2021
- Primary completion
- Apr 2022
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 4 trial of allergenic extract of birch, SQ SLIT-tablet in allergic rhinitis (AR), allergic conjunctivitis (AC), sponsored by Clinique Spécialisée en Allergie de la Capitale. Started Oct 2021; status: completed.
02
Drugs
allergenic extract of birchSQ SLIT-tablet
03
Conditions
allergic rhinitis (AR)allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT05119751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05119751.